Skip to content

Clinical trials

Observational Univentricular Heart trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Univentricular Heart Phase: Observational Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20071
20081
20131
20152
20162
20183
20192
20201
20211
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Active, not recruiting1
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Children's Hospital4
Children's Mercy Hospital Kansas City3
Emory University3
Children's Hospital of Philadelphia2
Children's Healthcare of Atlanta1
Children's Hospital Los Angeles1
Le Bonheur Children's Hospital1
Leiden University Medical Center1
Occlutech International AB1
Oregon Health and Science University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Univentricular Heart23
Heart Defects, Congenital13
Hypoplastic Left Heart Syndrome5
Heart Failure3
Congenital, Hereditary, and Neonatal Diseases and Abnormalities2
Congenital Abnormalities1
Congenitally Corrected Transposition of the Great Arteries1
Constriction, Pathologic1
Hypertension, Pulmonary1
Protein-Losing Enteropathies1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.